NPI: 1164481677 · PARMA, OH 44129 · General Acute Care Hospital · NPI assigned 03/22/2006
Authorized official SCHILLERO, ANTHONY controls 20+ related entities in our dataset. Read more
| Authorized Official | SCHILLERO, ANTHONY (DIRECTOR, FP&A) |
| NPI Enumeration Date | 03/22/2006 |
Other providers sharing the same authorized official: SCHILLERO, ANTHONY
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 41,681 | $1.21M |
| 2019 | 32,715 | $1.12M |
| 2020 | 17,128 | $855K |
| 2021 | 26,670 | $1.21M |
| 2022 | 34,847 | $1.47M |
| 2023 | 169,031 | $5.47M |
| 2024 | 136,233 | $4.35M |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 99283 | Emergency department visit for the evaluation and management, moderate severity | 28,445 | 26,334 | $3.22M |
| 99284 | Emergency department visit for the evaluation and management, high severity | 15,280 | 13,734 | $1.88M |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 7,409 | 5,313 | $1.59M |
| 99285 | Emergency department visit for the evaluation and management, high severity with immediate threat to life | 13,279 | 11,462 | $1.46M |
| 96361 | Intravenous infusion, hydration; each additional hour | 3,619 | 2,836 | $919K |
| 70450 | Computed tomography, head or brain; without contrast material | 3,611 | 2,972 | $755K |
| 99214 | Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 5,236 | 4,618 | $525K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 2,431 | 1,955 | $496K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | 6,484 | 2,545 | $461K |
| 99213 | Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 4,702 | 3,896 | $421K |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | 955 | 819 | $206K |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | 854 | 692 | $192K |
| 80053 | Comprehensive metabolic panel | 26,744 | 22,271 | $187K |
| 96366 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour | 924 | 586 | $179K |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | 923 | 751 | $172K |
| 71275 | Computed tomographic angiography, chest, with contrast material | 710 | 553 | $160K |
| 95810 | Polysomnography; sleep staging with 4 or more additional parameters | 226 | 208 | $160K |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | 397 | 309 | $146K |
| 92507 | Treatment of speech, language, voice, communication, and/or auditory processing disorder | 2,133 | 834 | $146K |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | 1,630 | 826 | $129K |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | 930 | 852 | $117K |
| 62323 | 310 | 287 | $117K | |
| G0378 | Hospital observation service, per hour | 1,877 | 964 | $95K |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | 593 | 516 | $94K |
| 97161 | 1,594 | 1,363 | $72K | |
| 80048 | Basic metabolic panel (calcium, ionized) | 8,359 | 5,620 | $71K |
| 99215 | Prolong outpt/office vis | 769 | 693 | $70K |
| 97140 | Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) | 2,310 | 993 | $64K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 592 | 547 | $62K |
| 92550 | 657 | 641 | $57K | |
| 11042 | Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm | 701 | 375 | $54K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 15,589 | 12,895 | $53K |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | 514 | 478 | $48K |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | 628 | 553 | $47K |
| 71260 | Computed tomography, thorax, diagnostic; with contrast material | 434 | 333 | $46K |
| 97113 | 620 | 184 | $45K | |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | 2,300 | 2,017 | $44K |
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | 1,319 | 732 | $44K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 521 | 453 | $41K |
| 87636 | Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B | 2,718 | 2,277 | $37K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 32,248 | 27,145 | $37K |
| 71250 | 446 | 410 | $37K | |
| 87637 | Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV | 1,098 | 925 | $35K |
| 97112 | Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination | 1,417 | 536 | $34K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 2,428 | 1,908 | $34K |
| 78452 | Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress | 98 | 79 | $34K |
| 71046 | Radiologic examination, chest; 2 views | 4,655 | 4,019 | $33K |
| 92557 | 786 | 769 | $31K | |
| 77063 | Screening digital breast tomosynthesis, bilateral | 697 | 650 | $30K |
| 84484 | 8,996 | 5,521 | $27K | |
| 93971 | 422 | 364 | $26K | |
| 97165 | 604 | 459 | $25K | |
| 71045 | Radiologic examination, chest; single view | 5,731 | 4,672 | $23K |
| 85027 | 6,077 | 3,757 | $22K | |
| 93017 | 287 | 239 | $21K | |
| 36415 | Collection of venous blood by venipuncture | 24,140 | 15,527 | $20K |
| 45385 | Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) | 45 | 34 | $20K |
| 76770 | 117 | 107 | $18K | |
| 82805 | 869 | 617 | $18K | |
| 76830 | Ultrasound, transvaginal | 563 | 484 | $16K |
| 86850 | 1,046 | 825 | $15K | |
| 76642 | 161 | 141 | $13K | |
| 72131 | 399 | 321 | $13K | |
| 73562 | 291 | 244 | $13K | |
| 73630 | 729 | 626 | $12K | |
| 74018 | 458 | 374 | $12K | |
| 70553 | Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences | 42 | 41 | $11K |
| 84443 | Thyroid stimulating hormone (TSH) | 1,567 | 1,330 | $11K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 9,104 | 7,732 | $11K |
| 73030 | 550 | 477 | $10K | |
| 95811 | 13 | 12 | $10K | |
| 20610 | 78 | 69 | $10K | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 2,315 | 1,977 | $9K |
| 80320 | 649 | 555 | $9K | |
| 72125 | Computed tomography, cervical spine; without contrast material | 1,227 | 1,003 | $9K |
| 83605 | 3,256 | 2,233 | $9K | |
| 77067 | Screening mammography, bilateral, including computer-aided detection | 698 | 651 | $8K |
| 86900 | 1,095 | 863 | $8K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 3,273 | 2,064 | $8K |
| 76536 | 80 | 69 | $7K | |
| 82947 | 4,613 | 1,799 | $7K | |
| 12001 | 48 | 44 | $7K | |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | 428 | 414 | $7K |
| 73130 | 584 | 501 | $7K | |
| 73610 | 578 | 503 | $7K | |
| 96375 | Therapeutic injection; each additional sequential IV push | 9,908 | 7,261 | $7K |
| 97116 | 264 | 119 | $6K | |
| 83735 | 4,971 | 3,380 | $6K | |
| 73110 | 339 | 305 | $6K | |
| 85610 | 4,210 | 3,129 | $5K | |
| 96368 | 4,427 | 2,918 | $5K | |
| 96367 | 162 | 127 | $5K | |
| 93970 | 46 | 40 | $5K | |
| 99291 | Critical care, evaluation and management of the critically ill patient, first 30-74 minutes | 55 | 40 | $5K |
| 73502 | 280 | 245 | $5K | |
| 90715 | 347 | 309 | $5K | |
| 72100 | 269 | 243 | $5K | |
| 80061 | Lipid panel | 699 | 611 | $5K |
| 87086 | Culture, bacterial; quantitative colony count, urine | 2,615 | 2,169 | $5K |
| 64483 | 14 | 13 | $4K | |
| 83036 | Hemoglobin; glycosylated (A1C) | 659 | 541 | $4K |
| 96376 | 1,506 | 819 | $4K | |
| 45380 | Colonoscopy, flexible; with biopsy, single or multiple | 15 | 12 | $4K |
| 31575 | 16 | 14 | $4K | |
| 81001 | 8,376 | 7,244 | $4K | |
| 73560 | 181 | 146 | $4K | |
| 86140 | 515 | 377 | $4K | |
| 31231 | 13 | 13 | $3K | |
| 0002A | 95 | 88 | $3K | |
| 99222 | Initial hospital care, per day, moderate complexity | 97 | 86 | $3K |
| 81003 | 4,795 | 4,209 | $3K | |
| 99152 | 235 | 159 | $3K | |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | 1,538 | 1,362 | $3K |
| J3490 | Unclassified drugs | 1,925 | 999 | $3K |
| 70486 | 121 | 111 | $3K | |
| 73564 | 276 | 236 | $3K | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 127 | 112 | $3K |
| 0001A | 91 | 91 | $2K | |
| 86901 | 1,095 | 863 | $2K | |
| 70551 | Magnetic resonance imaging, brain; without contrast material | 16 | 13 | $2K |
| 99401 | 25 | 25 | $2K | |
| 72148 | Magnetic resonance imaging, lumbar spine; without contrast material | 14 | 13 | $2K |
| 76000 | 47 | 42 | $2K | |
| 84702 | 1,464 | 1,205 | $2K | |
| 70496 | 16 | 12 | $2K | |
| 83880 | 1,484 | 1,169 | $2K | |
| 80069 | 277 | 182 | $2K | |
| 93975 | 16 | 13 | $2K | |
| 12011 | 12 | 12 | $2K | |
| 72128 | 128 | 99 | $2K | |
| 81025 | 5,309 | 4,137 | $2K | |
| 82607 | 96 | 74 | $2K | |
| 99203 | Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 64 | 62 | $2K |
| 83690 | 4,383 | 3,578 | $1K | |
| 82728 | 92 | 80 | $1K | |
| 92523 | 18 | 13 | $1K | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | 379 | 327 | $1K |
| 97535 | Self-care/home management training, each 15 minutes | 70 | 24 | $1K |
| 80143 | 1,319 | 1,009 | $1K | |
| 82077 | 1,244 | 913 | $1K | |
| 72170 | 140 | 113 | $1K | |
| 87081 | 171 | 169 | $1K | |
| 83540 | 109 | 92 | $1K | |
| 85018 | 750 | 572 | $943.70 | |
| 85379 | 875 | 716 | $941.81 | |
| 87077 | 491 | 340 | $924.33 | |
| J1170 | Injection, hydromorphone, up to 4 mg | 1,423 | 806 | $904.80 |
| 85007 | 320 | 209 | $858.60 | |
| J2543 | Injection, piperacillin sodium/tazobactam sodium, 1 gram/0.125 grams (1.125 grams) | 245 | 113 | $827.98 |
| 87186 | 781 | 608 | $818.98 | |
| J2270 | Injection, morphine sulfate, up to 10 mg | 1,815 | 1,165 | $811.27 |
| 80076 | 485 | 336 | $807.62 | |
| 83550 | 88 | 76 | $791.12 | |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | 750 | 394 | $702.73 |
| 87040 | 918 | 390 | $688.33 | |
| 00731 | 270 | 228 | $682.71 | |
| 85730 | 1,248 | 957 | $663.44 | |
| 87634 | 120 | 104 | $615.22 | |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 214 | 188 | $589.76 |
| 77061 | 13 | 12 | $571.54 | |
| 46083 | 14 | 13 | $570.48 | |
| 87631 | 26 | 26 | $568.44 | |
| 85014 | 109 | 87 | $562.05 | |
| 93296 | 24 | 24 | $555.16 | |
| J7030 | Infusion, normal saline solution , 1000 cc | 4,742 | 3,786 | $535.93 |
| J8499 | Prescription drug, oral, non chemotherapeutic, nos | 1,346 | 387 | $532.47 |
| 99204 | Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | 13 | 13 | $528.71 |
| 80179 | 1,302 | 1,005 | $526.70 | |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 215 | 189 | $516.85 |
| 87075 | 823 | 501 | $516.10 | |
| J1644 | Injection, heparin sodium, per 1000 units | 1,388 | 544 | $510.74 |
| 87070 | 355 | 281 | $508.26 | |
| 84439 | 42 | 41 | $488.27 | |
| 82248 | 344 | 276 | $487.46 | |
| A9270 | Non-covered item or service | 8,693 | 1,071 | $480.36 |
| C9113 | Injection, pantoprazole sodium, per vial | 259 | 120 | $479.88 |
| J1650 | Injection, enoxaparin sodium, 10 mg | 750 | 292 | $478.79 |
| 0004A | 12 | 12 | $464.12 | |
| 72040 | 13 | 13 | $439.84 | |
| 80164 | 30 | 25 | $436.92 | |
| 73140 | 17 | 12 | $436.10 | |
| 82746 | 49 | 37 | $409.19 | |
| J7120 | Ringers lactate infusion, up to 1000 cc | 3,322 | 2,361 | $359.45 |
| 77065 | Tomosynthesis, mammo | 15 | 13 | $342.69 |
| 88142 | 29 | 27 | $339.42 | |
| 84132 | 599 | 456 | $333.22 | |
| 99153 | Mod sedat endo service >5yrs | 63 | 45 | $330.62 |
| 99231 | Subsequent hospital care, per day, straightforward or low complexity | 33 | 12 | $313.28 |
| 87800 | 104 | 91 | $297.12 | |
| 82330 | 445 | 348 | $291.75 | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | 9,269 | 6,877 | $287.19 |
| 84100 | 143 | 103 | $284.64 | |
| 87205 | 331 | 262 | $266.05 | |
| 80329 | 116 | 83 | $263.25 | |
| 76801 | 13 | 13 | $256.50 | |
| 82550 | 207 | 164 | $229.56 | |
| J1815 | Injection, insulin, per 5 units | 180 | 63 | $218.78 |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | 269 | 182 | $211.44 |
| J2704 | Injection, propofol, 10 mg | 7,516 | 5,367 | $207.05 |
| 87661 | Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe | 65 | 58 | $197.07 |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 1,143 | 836 | $193.17 |
| G0404 | Electrocardiogram, routine ecg with 12 leads; tracing only, without interpretation and report, performed as a screening for the initial preventive physical examination | 81 | 66 | $185.52 |
| 82140 | 37 | 26 | $177.40 | |
| J7999 | Compounded drug, not otherwise classified | 558 | 449 | $177.13 |
| J7060 | 5% dextrose/water (500 ml = 1 unit) | 4,600 | 3,253 | $168.49 |
| 85652 | 263 | 195 | $167.88 | |
| 82150 | 177 | 168 | $163.90 | |
| 84481 | 12 | 12 | $158.10 | |
| 82570 | 101 | 91 | $151.73 | |
| 82435 | 401 | 317 | $150.94 | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | 880 | 573 | $124.38 |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | 6,575 | 4,835 | $112.85 |
| J3475 | Injection, magnesium sulfate, per 500 mg | 564 | 398 | $109.81 |
| J3370 | Injection, vancomycin hcl, 500 mg | 257 | 127 | $104.70 |
| 94761 | 615 | 472 | $104.23 | |
| 73090 | 14 | 12 | $101.26 | |
| 84295 | 400 | 317 | $87.89 | |
| J3010 | Injection, fentanyl citrate, 0.1 mg | 2,072 | 1,532 | $70.97 |
| J2765 | Injection, metoclopramide hcl, up to 10 mg | 852 | 626 | $66.72 |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | 868 | 627 | $61.73 |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 4,454 | 3,557 | $60.57 |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 394 | 351 | $57.07 |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | 99 | 76 | $49.35 |
| 86308 | 20 | 15 | $47.57 | |
| J0690 | Injection, cefazolin sodium, 500 mg | 341 | 233 | $44.42 |
| J1630 | Injection, haloperidol, up to 5 mg | 160 | 111 | $44.11 |
| J0689 | Injection, cefazolin sodium (baxter), not therapeutically equivalent to j0690, 500 mg | 673 | 486 | $41.60 |
| J7040 | Infusion, normal saline solution, sterile (500 ml = 1 unit) | 3,073 | 2,003 | $37.91 |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | 2,078 | 1,530 | $37.63 |
| 87210 | 72 | 68 | $36.14 | |
| 86403 | 127 | 123 | $32.29 | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | 1,319 | 1,061 | $31.28 |
| J2060 | Injection, lorazepam, 2 mg | 157 | 120 | $30.90 |
| 82010 | 17 | 13 | $28.47 | |
| J2360 | Injection, orphenadrine citrate, up to 60 mg | 145 | 129 | $28.18 |
| J1040 | Injection, methylprednisolone acetate, 80 mg | 114 | 91 | $22.06 |
| J2001 | Injection, lidocaine hcl for intravenous infusion, 10 mg | 3,535 | 2,665 | $19.87 |
| A4217 | Sterile water/saline, 500 ml | 370 | 273 | $19.86 |
| J8540 | Dexamethasone, oral, 0.25 mg | 136 | 76 | $17.20 |
| J2919 | Injection, methylprednisolone sodium succinate, 5 mg | 16 | 12 | $15.59 |
| 80305 | 214 | 188 | $14.70 | |
| J2795 | Injection, ropivacaine hydrochloride, 1 mg | 179 | 145 | $14.35 |
| J7512 | Prednisone, immediate release or delayed release, oral, 1 mg | 482 | 329 | $13.05 |
| J1010 | Injection, methylprednisolone acetate, 1 mg | 122 | 114 | $10.92 |
| J1171 | Injection, hydromorphone, 0.1 mg | 133 | 93 | $7.74 |
| J0665 | Injection, bupivicaine, not otherwise specified, 0.5 mg | 279 | 240 | $7.32 |
| J2175 | Injection, meperidine hydrochloride, per 100 mg | 113 | 82 | $7.30 |
| J7050 | Infusion, normal saline solution, 250 cc | 232 | 184 | $6.27 |
| J2470 | Injection, pantoprazole sodium, 40 mg | 14 | 12 | $5.56 |
| J2272 | Injection, morphine sulfate (fresenius kabi), not therapeutically equivalent to j2270, up to 10 mg | 18 | 17 | $5.20 |
| J7620 | Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme | 213 | 159 | $2.56 |
| J3480 | Injection, potassium chloride, per 2 meq | 31 | 26 | $2.26 |
| 91300 | 233 | 202 | $1.87 | |
| Q9966 | Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml | 113 | 101 | $0.34 |
| 3008F | 109 | 98 | $0.00 | |
| C1769 | Guide wire | 166 | 122 | $0.00 |
| 1036F | 63 | 56 | $0.00 | |
| 76377 | 93 | 72 | $0.00 | |
| 94760 | 120 | 76 | $0.00 | |
| J2003 | Injection, lidocaine hydrochloride, 1 mg | 704 | 579 | $0.00 |
| 84075 | 30 | 29 | $0.00 | |
| J1030 | Injection, methylprednisolone acetate, 40 mg | 16 | 12 | $0.00 |
| J2785 | Injection, regadenoson, 0.1 mg | 54 | 39 | $0.00 |
| J7613 | Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg | 18 | 12 | $0.00 |
| 00813 | 24 | 14 | $0.00 | |
| A9575 | Injection, gadoterate meglumine, 0.1 ml | 482 | 406 | $0.00 |
| 84460 | 30 | 29 | $0.00 | |
| C1713 | Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable) | 204 | 139 | $0.00 |
| Q9957 | Injection, perflutren lipid microspheres, per ml | 32 | 25 | $0.00 |
| 29125 | 21 | 15 | $0.00 | |
| 84450 | 30 | 29 | $0.00 | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 75 | 71 | $0.00 |
| J0780 | Injection, prochlorperazine, up to 10 mg | 15 | 13 | $0.00 |
| A9502 | Technetium tc-99m tetrofosmin, diagnostic, per study dose | 44 | 30 | $0.00 |
| G1004 | Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program | 25 | 16 | $0.00 |
| C1894 | Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser | 45 | 34 | $0.00 |
| 84155 | 30 | 29 | $0.00 | |
| C1887 | Catheter, guiding (may include infusion/perfusion capability) | 18 | 15 | $0.00 |
| J1596 | Injection, glycopyrrolate, 0.1 mg | 30 | 29 | $0.00 |
| 77003 | 19 | 17 | $0.00 | |
| 0753T | 19 | 12 | $0.00 | |
| 82247 | 30 | 29 | $0.00 | |
| C1760 | Closure device, vascular (implantable/insertable) | 14 | 13 | $0.00 |